Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Pays » - entrée « Italie »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Israël < Italie < Japon  Facettes :

List of bibliographic references indexed by Italie

Number of relevant bibliographic references: 290.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000016 (2021) Claudia Lilli ; Annibale Biggeri [Italie] ; Chiara Zingaretti ; Bernadette Vertogen ; Valeria Frassineti ; Roberto Vespignani ; Veruska Grossi ; Caterina Florescu ; Laura Matteucci ; Chiara Pazzi ; Alberto Bongiovanni ; Francesco Limarzi ; Valentina Fausti ; Lucia Bertoni ; Caterina Donati ; Francesca Galardi ; Nicola Gentili ; Francesco Mazza ; Giovanni Martinelli ; Oriana NanniIs it possible to conduct clinical trials during a pandemic? The example of a trial of hydroxychloroquine.
000020 (2021) Fabio Cruciani [Italie] ; Laura Amato [Italie] ; Franco De Crescenzo ; Zuzana Mitrova [Italie] ; Rosella Saulle [Italie] ; Simona Vecchi [Italie] ; Marina Davoli [Italie][The praise of uncertainty: a systematic living review to evaluate the efficacy and safety of drug treatments for patients with covid-19.]
000034 (2021) Ennio Giulio Favalli [Oman] ; Francesca Ingegnoli [Italie] ; Rolando Cimaz [Italie] ; Roberto Caporali [Italie]What is the true incidence of COVID-19 in patients with rheumatic diseases?
000035 (2021) L. Anedda [Italie] ; L. Bianchini ; L. Cuzzolin ; G. Finco ; V. Fanos ; M A MarcialisWhat if COVID-19 affects the child: which weapons and how to use them.
000054 (2021) Iván J. Nú Ez-Gil [Espagne] ; Antonio Fernández-Ortiz [Espagne] ; Charbel Maroud Eid [Espagne] ; Jia Huang [République populaire de Chine] ; Rodolfo Romero [Espagne] ; Victor Manuel Becerra-Mu Oz [Espagne] ; Aitor Uribarri [Espagne] ; Gisela Feltes ; Daniela Trabatoni [Italie] ; Inmaculada Fernandez-Rozas [Espagne] ; Maria C. Viana-Llamas [Espagne] ; Martino Pepe ; Enrico Cerrato [Italie] ; Maurizio Bertaina [Italie] ; Thamar Capel Astrua [Espagne] ; Emilio Alfonso [Cuba] ; Alex F. Castro-Mejía ; Sergio Raposeiras-Roubin ; Fabrizio D'Ascenzo ; Carolina Espejo Paeres [Espagne] ; Jaime Signes-Costa [Espagne] ; Alfredo Bardaji ; Cristina Fernandez-Pérez [Espagne] ; Francisco Marin [Espagne] ; Oscar Fabregat-Andres [Espagne] ; Ibrahim Akin [Allemagne] ; Vicente Estrada [Espagne] ; Carlos Macaya [Espagne]Underlying heart diseases and acute COVID-19 outcomes.
000081 (2021) Edoardo Sciatti [Italie] ; Claudio Ceconi [Italie]The strange case of hydroxychloroquine and COVID-19.
000098 (2021) Antonio Desai [Italie] ; Giuseppe Caltagirone [Italie] ; Sharon Sari [Italie] ; Daria Pocaterra [Italie] ; Maria Kogan [Italie] ; Elena Azzolini [Italie] ; Victor Savevski [Italie] ; Filippo Martinelli-Boneschi [Italie] ; Antonio Voza [Italie] ; On Behalf Of The Humanitas Covid-Task Force [Italie]The Use of Antiviral Agents against SARS-CoV-2: Ineffective or Time and Age Dependent Result? A Retrospective, Observational Study among COVID-19 Older Adults.
000101 (2021) L. Bonzano [Italie] ; G. Cassone [Italie] ; L. Tarallo [Italie] ; G. Pellacani [Italie]The Rediscovery of Hydroxychloroquine in Allergic Diseases in the COVID-19 Era.
000114 (2021) Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Bhanuprasad Venkatesalu [États-Unis] ; Harsh K. Patel [États-Unis] ; Marco Spadaccini [Italie] ; Jacob Manteuffel [États-Unis] ; Mayur Ramesh [États-Unis]Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection.
000118 (2021) Carlo Salvarani [Italie] ; Pamela Mancuso [Italie] ; Federica Gradellini [Italie] ; Nilla Viani [Italie] ; Paolo Pandolfi [Italie] ; Massimo Reta [Italie] ; Giuliano Carrozzi [Italie] ; Gilda Sandri [Italie] ; Gianluigi Bajocchi [Italie] ; Elena Galli [Italie] ; Francesco Muratore [Italie] ; Luigi Boiardi [Italie] ; Nicol Pipitone [Italie] ; Giulia Cassone [Italie] ; Stefania Croci [Italie] ; Anna Maria Marata [Italie] ; Massimo Costantini [Italie] ; Paolo Giorgi Rossi [Italie]Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy.
000119 (2021) Waleed Alhazzani [Canada] ; Laura Evans [États-Unis] ; Fayez Alshamsi [Émirats arabes unis] ; Morten Hylander M Ller [Danemark] ; Marlies Ostermann [Royaume-Uni] ; Hallie C. Prescott [États-Unis] ; Yaseen M. Arabi ; Mark Loeb [Canada] ; Michelle Ng Gong [États-Unis] ; Eddy Fan [Canada] ; Simon Oczkowski [Canada] ; Mitchell M. Levy [États-Unis] ; Lennie Derde [Pays-Bas] ; Amy Dzierba [États-Unis] ; Bin Du [République populaire de Chine] ; Flavia Machado [Brésil] ; Hannah Wunsch [Canada] ; Mark Crowther [Canada] ; Maurizio Cecconi [Italie] ; Younsuck Koh [Corée du Sud] ; Lisa Burry [Canada] ; Daniel S. Chertow [États-Unis] ; Wojciech Szczeklik [Pologne] ; Emilie Belley-Cote [Canada] ; Massimiliano Greco [Italie] ; Malgorzata Bala [Pologne] ; Ryan Zarychanski [Canada] ; Jozef Kesecioglu [Pays-Bas] ; Allison Mcgeer [Canada] ; Leonard Mermel [États-Unis] ; Manoj J. Mammen [États-Unis] ; Sheila Nainan Myatra [Inde] ; Amy Arrington [États-Unis] ; Ruth Kleinpell [États-Unis] ; Giuseppe Citerio [Italie] ; Kimberley Lewis [Canada] ; Elizabeth Bridges [États-Unis] ; Ziad A. Memish ; Naomi Hammond [Australie] ; Frederick G. Hayden [États-Unis] ; Muhammed Alshahrani [Arabie saoudite] ; Zainab Al Duhailib [Canada, Arabie saoudite] ; Greg S. Martin [États-Unis] ; Lewis J. Kaplan [États-Unis] ; Craig M. Coopersmith [États-Unis] ; Massimo Antonelli [Italie] ; Andrew Rhodes [Royaume-Uni]Surviving Sepsis Campaign Guidelines on the Management of Adults With Coronavirus Disease 2019 (COVID-19) in the ICU: First Update.
000120 (2021) Giancarlo Ceccarelli [Italie] ; Francesco Alessandri [Italie] ; Alessandra Oliva [Italie] ; Serena Dell'Isola [Italie] ; Monica Rocco [Italie] ; Franco Ruberto [Italie] ; Francesco Pugliese [Italie] ; Gabriella D'Ettorre [Italie] ; Mario Venditti [Italie]Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent.
000122 (2021) Caterina Giannitto [Italie] ; Cristiana Bonifacio [Italie] ; Susanna Esposito [Italie] ; Angela Ammirabile [Italie] ; Giuseppe Mercante [Italie] ; Armando De Virgilio [Italie] ; Giuseppe Spriano [Italie] ; Enrico Heffler [Italie] ; Ludovica Lofino [Italie] ; Letterio Salvatore Politi [Italie] ; Luca Balzarini [Italie]Sudden neck swelling with rash as late manifestation of COVID-19: a case report.
000145 (2021) Giorgio Costagliola [Italie] ; Erika Spada [Italie] ; Rita Consolini [Italie]Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents.
000155 (2021) Alberto Enrico Maraolo [Italie] ; Adriano Grossi [Italie]Safety of hydroxychloroquine for treatment or prevention of SARS-CoV-2 infection: A rapid systematic review and meta-analysis of randomized clinical trials.
000166 (2021) Giulia Fiscon [Italie] ; Federica Conte [Italie] ; Lorenzo Farina [Italie] ; Paola Paci [Italie]SAveRUNNER: A network-based algorithm for drug repurposing and its application to COVID-19.
000184 (2021) Stefania Spila Alegiani [Italie] ; Salvatore Crisafulli [Italie] ; Paolo Giorgi Rossi [Italie] ; Pamela Mancuso [Italie] ; Carlo Salvarani [Italie] ; Fabiola Atzeni [Italie] ; Rosa Gini [Italie] ; Ursula Kirchmayer [Italie] ; Valeria Belleudi [Italie] ; Peter Konstantin Kurotschka [Italie] ; Olivia Leoni [Italie] ; Monica Ludergnani [Italie] ; Eliana Ferroni [Italie] ; Susanna Baracco [Italie] ; Marco Massari [Italie] ; Gianluca Trifir [Italie]Risk of COVID-19 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional DMARDs in Italy.
000197 (2021) Paolo Agostinis [Italie] ; Valentina Vianello [Italie] ; Elena Dereani [Italie] ; Giuseppe Caruso [Italie] ; Beatrice Montessoro [Italie] ; Marco Taurian [Italie] ; Antonio Di Chiara [Italie] ; Vincenzo Patruno [Italie] ; Francesco Cavallin [Italie] ; Gian Paolo Fadini [Italie] ; Anna Aldovini [États-Unis] ; Anna Baritussio [Italie] ; Francesco Curcio [Italie] ; Carlo Tascini [Italie] ; Aldo Baritussio [Italie]Response to a massive SARS-CoV-2 infection in a nursing home transformed into a caring center.
000198 (2021) Francesca Romana Spinelli [Italie] ; Fulvia Ceccarelli [Italie] ; Manuela Di Franco [Italie] ; Fabrizio Conti [Italie]Response to 'To consider or not antimalarials as a prophylactic intervention in the SARS-CoV-2 (Covid-19) pandemic' by Parperis.
000199 (2021) Francesca Romana Spinelli [Italie] ; Fulvia Ceccarelli [Italie] ; Manuela Di Franco [Italie] ; Fabrizio Conti [Italie]Response to 'Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?' by Moiseev et al.
000237 (2021) Matteo Bianco [Italie] ; Carlo Alberto Biolè [Italie] ; Enrico Cerrato [Italie]QT Interval in Patients With COVID-19.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffPays.i -k "Italie" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffPays.i  \
                -Sk "Italie" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AffPays.i
   |clé=    Italie
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021